surrogate virus neutralization test (svnt) Search Results



90
GenScript corporation surrogated viral neutralization test (svnt
Surrogated Viral Neutralization Test (Svnt, supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/surrogate+virus+neutralization+test+(svnt)/surrogate+virus+neutralization+test++svnt+/ppr0476306-3-20-34
Average 90 stars, based on 1 article reviews
surrogated viral neutralization test (svnt - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
AffinityImmuno inc elisa-based sars-cov-2 surrogate virus neutralization test (svnt)
In silico analyses of vaccine antigen. ( A ) Variations detected in Spike gene of 20 <t>SARS-CoV-2</t> isolates collected from various provinces of Türkiye. The map in figure was generated by Microsoft 365 Excel. ( B ) A1841G mutation causes D614G amino acid alteration ( C ) 3D image of human ACE2 receptor docked with Wuhan Spike protein and coSpikeD614G vaccine antigen. Purple color: Spike protein; blue color: receptor binding domain (RBD) of Spike protein; green color: human ACE2 receptor; red color: receptor binding motif of human ACE2 protein.
Elisa Based Sars Cov 2 Surrogate Virus Neutralization Test (Svnt), supplied by AffinityImmuno inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/surrogate+virus+neutralization+test+(svnt)/sars+cov+2+surrogate+virus+neutralization+test++svnt/pmc11180131-98-12-26
Average 90 stars, based on 1 article reviews
elisa-based sars-cov-2 surrogate virus neutralization test (svnt) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
EUROIMMUN surrogate virus neutralization tests
In silico analyses of vaccine antigen. ( A ) Variations detected in Spike gene of 20 <t>SARS-CoV-2</t> isolates collected from various provinces of Türkiye. The map in figure was generated by Microsoft 365 Excel. ( B ) A1841G mutation causes D614G amino acid alteration ( C ) 3D image of human ACE2 receptor docked with Wuhan Spike protein and coSpikeD614G vaccine antigen. Purple color: Spike protein; blue color: receptor binding domain (RBD) of Spike protein; green color: human ACE2 receptor; red color: receptor binding motif of human ACE2 protein.
Surrogate Virus Neutralization Tests, supplied by EUROIMMUN, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/surrogate+virus+neutralization+test+(svnt)/surrogate+virus+neutralization+test++svnt+/pmc10573711-150-17-25
Average 90 stars, based on 1 article reviews
surrogate virus neutralization tests - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Shenzhen YHLO surrogate virus neutralization test (svnt)
In silico analyses of vaccine antigen. ( A ) Variations detected in Spike gene of 20 <t>SARS-CoV-2</t> isolates collected from various provinces of Türkiye. The map in figure was generated by Microsoft 365 Excel. ( B ) A1841G mutation causes D614G amino acid alteration ( C ) 3D image of human ACE2 receptor docked with Wuhan Spike protein and coSpikeD614G vaccine antigen. Purple color: Spike protein; blue color: receptor binding domain (RBD) of Spike protein; green color: human ACE2 receptor; red color: receptor binding motif of human ACE2 protein.
Surrogate Virus Neutralization Test (Svnt), supplied by Shenzhen YHLO, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/surrogate+virus+neutralization+test+(svnt)/surrogate+virus+neutralization+test++svnt+/pmc08468564-8-17-32
Average 90 stars, based on 1 article reviews
surrogate virus neutralization test (svnt) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Pishtaz Teb surrogate virus neutralization test (svnt)
In silico analyses of vaccine antigen. ( A ) Variations detected in Spike gene of 20 <t>SARS-CoV-2</t> isolates collected from various provinces of Türkiye. The map in figure was generated by Microsoft 365 Excel. ( B ) A1841G mutation causes D614G amino acid alteration ( C ) 3D image of human ACE2 receptor docked with Wuhan Spike protein and coSpikeD614G vaccine antigen. Purple color: Spike protein; blue color: receptor binding domain (RBD) of Spike protein; green color: human ACE2 receptor; red color: receptor binding motif of human ACE2 protein.
Surrogate Virus Neutralization Test (Svnt), supplied by Pishtaz Teb, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/surrogate+virus+neutralization+test+(svnt)/surrogate+virus+neutralization+test++svnt+/pm38753442-89-0-5
Average 90 stars, based on 1 article reviews
surrogate virus neutralization test (svnt) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Surro Immunology elisa-based surrogate virus neutralization test (svnt)
In silico analyses of vaccine antigen. ( A ) Variations detected in Spike gene of 20 <t>SARS-CoV-2</t> isolates collected from various provinces of Türkiye. The map in figure was generated by Microsoft 365 Excel. ( B ) A1841G mutation causes D614G amino acid alteration ( C ) 3D image of human ACE2 receptor docked with Wuhan Spike protein and coSpikeD614G vaccine antigen. Purple color: Spike protein; blue color: receptor binding domain (RBD) of Spike protein; green color: human ACE2 receptor; red color: receptor binding motif of human ACE2 protein.
Elisa Based Surrogate Virus Neutralization Test (Svnt), supplied by Surro Immunology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/surrogate+virus+neutralization+test+(svnt)/elisa+based+surrogate+virus+neutralization+test++svnt+/pm35891235-282-61-59
Average 90 stars, based on 1 article reviews
elisa-based surrogate virus neutralization test (svnt) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


In silico analyses of vaccine antigen. ( A ) Variations detected in Spike gene of 20 SARS-CoV-2 isolates collected from various provinces of Türkiye. The map in figure was generated by Microsoft 365 Excel. ( B ) A1841G mutation causes D614G amino acid alteration ( C ) 3D image of human ACE2 receptor docked with Wuhan Spike protein and coSpikeD614G vaccine antigen. Purple color: Spike protein; blue color: receptor binding domain (RBD) of Spike protein; green color: human ACE2 receptor; red color: receptor binding motif of human ACE2 protein.

Journal: Scientific Reports

Article Title: Immunogenicity and protection efficacy of a COVID-19 DNA vaccine encoding spike protein with D614G mutation and optimization of large-scale DNA vaccine production

doi: 10.1038/s41598-024-64690-5

Figure Lengend Snippet: In silico analyses of vaccine antigen. ( A ) Variations detected in Spike gene of 20 SARS-CoV-2 isolates collected from various provinces of Türkiye. The map in figure was generated by Microsoft 365 Excel. ( B ) A1841G mutation causes D614G amino acid alteration ( C ) 3D image of human ACE2 receptor docked with Wuhan Spike protein and coSpikeD614G vaccine antigen. Purple color: Spike protein; blue color: receptor binding domain (RBD) of Spike protein; green color: human ACE2 receptor; red color: receptor binding motif of human ACE2 protein.

Article Snippet: Neutralizing antibody responses in vaccinated mice sera were analyzed using an ELISA-based SARS-CoV-2 surrogate Virus Neutralization Test (sVNT) which is a S1 protein/ACE2 ligand binding assay) (AffinityImmuno, Canada) according to the manufacturer’s protocol.

Techniques: In Silico, Generated, Mutagenesis, Binding Assay

Animal studies and humoral immune response elicited by pcoSpikeD614G DNA vaccine. ( A ) Brief timeline of animal studies. BALB/c mice were immunized to assess the immunogenicity and K18-hACE2 transgenic mice were immunized to determine protective efficacy conferred by pcoSpikeD614G DNA vaccine ( B ) Western blot image shows the presence of anti-S1 and anti S1 + S2 antibody responses in sera of vaccinated BALB/c mice. Lane 1: Protein ladder; Lanes 2 and 3: recombinant S1 protein probed with pooled pcoSpikeD614G vaccinated mice sera immunized thrice through ID + EP and IM routes. Red arrowheads show the recombinant S1 proteins with a size of over \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\sim$$\end{document} ∼ 76.41 kDa due to glycosylation; Lanes 4 and 5: recombinant S1 + S2 protein pooled with pcoSpikeD614G vaccinated mice sera immunized thrice through ID + EP and IM routes. Blue arrowheads show the recombinant S1 + S2 proteins with a size of over \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\sim$$\end{document} ∼ 138.5 kDa due to glycosylation; Lane 6–7 and 8–9: recombinant S1 and S1 + S2 proteins probed with pooled vaccinated mice sera administered with empty pVAX1. Original Western blot images have been shown in Supplementary file named S5 Figure ( C ) The anti-S1 IgG kinetics derived from mice immunized with pcoSpikeD614G administered through ID + EP and IM routes show significant increase at day 70 compared to controls ( D ) IgG2a/IgG1 polarization was assessed at days 0 and 70 for empty pVAX1 and pcoSpikeD614G and IgG2a responses were significantly higher ( E ) The ratio of IgG2a/IgG1 is slightly higher in pcoSpikeD614G administered through IM route ( F ) SARS-CoV-2 Surrogate Virus Neutralization Test showed that inhibition potential of 1:10 diluted sera obtained from vaccinated mice at day 70 was significantly higher than controls ( G ) SARS-CoV-2 50% neutralization titers (VNT50) in sera of in pcoSpikeD614G immunized mice collated on day 70. Data are presented as GMT ± SD.

Journal: Scientific Reports

Article Title: Immunogenicity and protection efficacy of a COVID-19 DNA vaccine encoding spike protein with D614G mutation and optimization of large-scale DNA vaccine production

doi: 10.1038/s41598-024-64690-5

Figure Lengend Snippet: Animal studies and humoral immune response elicited by pcoSpikeD614G DNA vaccine. ( A ) Brief timeline of animal studies. BALB/c mice were immunized to assess the immunogenicity and K18-hACE2 transgenic mice were immunized to determine protective efficacy conferred by pcoSpikeD614G DNA vaccine ( B ) Western blot image shows the presence of anti-S1 and anti S1 + S2 antibody responses in sera of vaccinated BALB/c mice. Lane 1: Protein ladder; Lanes 2 and 3: recombinant S1 protein probed with pooled pcoSpikeD614G vaccinated mice sera immunized thrice through ID + EP and IM routes. Red arrowheads show the recombinant S1 proteins with a size of over \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\sim$$\end{document} ∼ 76.41 kDa due to glycosylation; Lanes 4 and 5: recombinant S1 + S2 protein pooled with pcoSpikeD614G vaccinated mice sera immunized thrice through ID + EP and IM routes. Blue arrowheads show the recombinant S1 + S2 proteins with a size of over \documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$\sim$$\end{document} ∼ 138.5 kDa due to glycosylation; Lane 6–7 and 8–9: recombinant S1 and S1 + S2 proteins probed with pooled vaccinated mice sera administered with empty pVAX1. Original Western blot images have been shown in Supplementary file named S5 Figure ( C ) The anti-S1 IgG kinetics derived from mice immunized with pcoSpikeD614G administered through ID + EP and IM routes show significant increase at day 70 compared to controls ( D ) IgG2a/IgG1 polarization was assessed at days 0 and 70 for empty pVAX1 and pcoSpikeD614G and IgG2a responses were significantly higher ( E ) The ratio of IgG2a/IgG1 is slightly higher in pcoSpikeD614G administered through IM route ( F ) SARS-CoV-2 Surrogate Virus Neutralization Test showed that inhibition potential of 1:10 diluted sera obtained from vaccinated mice at day 70 was significantly higher than controls ( G ) SARS-CoV-2 50% neutralization titers (VNT50) in sera of in pcoSpikeD614G immunized mice collated on day 70. Data are presented as GMT ± SD.

Article Snippet: Neutralizing antibody responses in vaccinated mice sera were analyzed using an ELISA-based SARS-CoV-2 surrogate Virus Neutralization Test (sVNT) which is a S1 protein/ACE2 ligand binding assay) (AffinityImmuno, Canada) according to the manufacturer’s protocol.

Techniques: Transgenic Assay, Western Blot, Recombinant, Derivative Assay, Virus, Neutralization, Inhibition

Protection conferred by pcoSpikeD614G DNA vaccine in K18-hACE2 transgenic mice challenged by SARS-CoV-2. ( A ) Gross pathological scoring of lungs to evaluate the level of pneumonia. Healthy lungs were scored as 0, edema-hyperemia between 0.5 and 1, pneumonia lesions were between 1.5 and 5 and dead mice were scored as 5. ( B ) Mean Ct values of RT-qPCR targeting NC gene of SARS‐CoV‐2 derived from the lungs of mice. The virus load is represented by Crossing point threshold (Ct) values. The Ct value of a negative PCR sample is accepted as 40 ( C ) Histopathology scoring of lungs to evaluate the level of inflammation status. Absence of inflammation is represented by 0 and various level of inflammation were scored between 1 and 3. Three lungs from the control group and one lung from the mice group immunized with pcoSpikeD614G administered through IM route were not scored ( D, E ) In the group of mice immunized with pcoSpikeD614G administered through IM route, images show normal lungs at magnifications of 4 × and 10 × . Arrow shows alveoli with normal morphology ( F, G ) In the group of mice immunized with pcoSpikeD614G administered through ID + EP route, images show normal lungs at magnifications of 4 × and 10 × . Arrow shows alveoli with normal morphology. ( H, I ) In the control group of mice, images show lungs with interstitial inflammatory cell infiltration at magnifications of 4 × and 10 × . Asterisks indicate areas of lymphocyte infiltration in the interalveolar spaces. ( J ) Kaplan–Meier Survival analysis after intranasal instillation of 10 5 TCID 50 virus for 3 consecutive days.

Journal: Scientific Reports

Article Title: Immunogenicity and protection efficacy of a COVID-19 DNA vaccine encoding spike protein with D614G mutation and optimization of large-scale DNA vaccine production

doi: 10.1038/s41598-024-64690-5

Figure Lengend Snippet: Protection conferred by pcoSpikeD614G DNA vaccine in K18-hACE2 transgenic mice challenged by SARS-CoV-2. ( A ) Gross pathological scoring of lungs to evaluate the level of pneumonia. Healthy lungs were scored as 0, edema-hyperemia between 0.5 and 1, pneumonia lesions were between 1.5 and 5 and dead mice were scored as 5. ( B ) Mean Ct values of RT-qPCR targeting NC gene of SARS‐CoV‐2 derived from the lungs of mice. The virus load is represented by Crossing point threshold (Ct) values. The Ct value of a negative PCR sample is accepted as 40 ( C ) Histopathology scoring of lungs to evaluate the level of inflammation status. Absence of inflammation is represented by 0 and various level of inflammation were scored between 1 and 3. Three lungs from the control group and one lung from the mice group immunized with pcoSpikeD614G administered through IM route were not scored ( D, E ) In the group of mice immunized with pcoSpikeD614G administered through IM route, images show normal lungs at magnifications of 4 × and 10 × . Arrow shows alveoli with normal morphology ( F, G ) In the group of mice immunized with pcoSpikeD614G administered through ID + EP route, images show normal lungs at magnifications of 4 × and 10 × . Arrow shows alveoli with normal morphology. ( H, I ) In the control group of mice, images show lungs with interstitial inflammatory cell infiltration at magnifications of 4 × and 10 × . Asterisks indicate areas of lymphocyte infiltration in the interalveolar spaces. ( J ) Kaplan–Meier Survival analysis after intranasal instillation of 10 5 TCID 50 virus for 3 consecutive days.

Article Snippet: Neutralizing antibody responses in vaccinated mice sera were analyzed using an ELISA-based SARS-CoV-2 surrogate Virus Neutralization Test (sVNT) which is a S1 protein/ACE2 ligand binding assay) (AffinityImmuno, Canada) according to the manufacturer’s protocol.

Techniques: Transgenic Assay, Quantitative RT-PCR, Derivative Assay, Virus, Histopathology